U.S. Lifts Pause on J&J's Covid Vaccine--Update
By Peter Loftus Vaccinations with Johnson & Johnson's Covid-19 shot should resume, U.S. health regulators said after investigating rare blood-clotting cases, restoring a key tool for filling gaps in the mass vaccination campaign. To alert doctors and recipients to the condition that led to a pause in the vaccine's use last week, J&J and regulators plan to add language to the shot's label and fact sheets warning of the clotting condition risk. The U.S. Food and Drug Administration and U.S. Centers for Disease Control and Prevention on Friday lifted their recommendation to pau...